Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WWE
426
DELISTED
World Wrestling Entertainment
WWE
| $40.2M | 0.06% |
463,450
+274,531
| +145% | +$23.1M |
|
427
Sun Communities
SUI
$15.1B
| $39.7M | 0.06% |
335,061
-217,705
| -39% | -$24.2M |
|
428
PUT
Lennox International
LII
$19B
| $39.7M | 0.06% |
+150,000
| New | +$35.9M |
|
|
NVO
429
Novo Nordisk
NVO
$221B
| $39.6M | 0.06% |
1,513,684
-143,858
| -9% | -$3.54M |
|
|
MXIM
430
DELISTED
Maxim Integrated Products
MXIM
| $39.5M | 0.06% |
742,951
-713,962
| -49% | -$38.4M |
|
431
Takeda Pharmaceutical
TAK
$55.9B
| $39.5M | 0.06% |
1,939,209
+1,926,409
| +15,050% | +$38.8M |
|
432
TG Therapeutics
TGTX
$8.57B
| $39.4M | 0.06% |
4,905,786
+4,786,175
| +4,001% | +$25.9M |
|
433
Steel Dynamics
STLD
$35.4B
| $39.4M | 0.06% |
1,117,080
-1,624,906
| -59% | -$57.7M |
|
434
Vornado Realty Trust
VNO
$7.46B
| $39.2M | 0.06% |
581,227
+558,093
| +2,412% | +$37.4M |
|
435
TechnipFMC
FTI
$30.1B
| $39.2M | 0.06% |
2,238,576
+1,191,003
| +114% | +$20.1M |
|
436
Southwest Airlines
LUV
$22.1B
| $38.9M | 0.06% |
750,063
-3,842,194
| -84% | -$203M |
|
|
GHDX
437
DELISTED
Genomic Health, Inc.
GHDX
| $38.9M | 0.06% |
555,700
-62,487
| -10% | -$4.63M |
|
438
Pultegroup
PHM
$24.6B
| $38.8M | 0.06% |
1,388,026
-2,714,075
| -66% | -$74M |
|
439
West Pharmaceutical
WST
$23.3B
| $38.8M | 0.06% |
352,016
+200,268
| +132% | +$20.8M |
|
440
Coca-Cola Europacific Partners
CCEP
$48B
| $38.8M | 0.06% |
749,598
-588,465
| -44% | -$27.9M |
|
|
JNPR
441
DELISTED
Juniper Networks
JNPR
| $38.5M | 0.06% |
1,452,968
-173,998
| -11% | -$4.69M |
|
442
Avista
AVA
$3.45B
| $38.4M | 0.06% |
944,951
+885,662
| +1,494% | +$36.4M |
|
443
Live Nation Entertainment
LYV
$41.6B
| $38.4M | 0.06% |
603,659
+442,042
| +274% | +$25.1M |
|
444
Dropbox
DBX
$7.15B
| $38.3M | 0.06% |
1,758,379
+958,571
| +120% | +$22.3M |
|
445
PUT
State Street SPDR S&P Retail ETF
XRT
$447M
| $38.3M | 0.06% |
+851,000
| New | +$37.8M |
|
446
Encompass Health
EHC
$11.4B
| $38.3M | 0.06% |
824,217
+475,508
| +136% | +$24.1M |
|
447
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $38.3M | 0.06% |
454,733
-17,368
| -4% | -$1.45M |
|
448
Saic
SAIC
$5.02B
| $38.2M | 0.06% |
495,794
+488,642
| +6,832% | +$34.4M |
|
449
Fortune Brands Innovations
FBIN
$6.1B
| $38.1M | 0.06% |
936,642
+60,073
| +7% | +$2.31M |
|
450
PUT
Adobe
ADBE
$95.6B
| $38.1M | 0.06% |
143,000
+74,900
| +110% | +$18.9M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.